Chengyin H. Lv
300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Clinical and molecular characterization of ILD in patients with overlapping ASyS and SjD: a retrospective observational study.
Journal: Rheumatology (Oxford, England)
Published: June 18, 2025
Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study.
Journal: Clinical and experimental rheumatology
Published: May 12, 2024
Value of radiomics-based automatic grading of muscle edema in polymyositis/dermatomyositis based on MRI fat-suppressed T2-weighted images.
Journal: Acta radiologica (Stockholm, Sweden : 1987)
Published: April 09, 2024
Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis.
Journal: Arthritis research & therapy
Published: September 21, 2023
Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model.
Journal: Frontiers in immunology
Published: September 01, 2023
Elevated serum B-cell activator factor levels predict rapid progressive interstitial lung disease in anti-melanoma differentiation associated protein 5 antibody positive dermatomyositis.
Journal: Orphanet journal of rare diseases
Published: August 13, 2023
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk.
Journal: The Journal of rheumatology
Published: June 02, 2022
Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China.
Journal: Rheumatology (Oxford, England)
Published: March 25, 2022
Brain-Reactive Antibodies are Potential Biomarkers for Evaluating Therapeutic Efficacy in NPSLE Patients.
Journal: Neuropsychiatric disease and treatment
Published: January 24, 2022
Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 06, 2022
Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China.
Journal: Emerging microbes & infections
Published: November 10, 2021
Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease.
Journal: Clinical and experimental rheumatology
Published: August 27, 2021
Last Updated: 09/26/2026